Cargando…
Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
Background. Serum cystatin C (CysC) was proposed as an effective reflection of the glomerular filtration rate (GFR). However, its role in patients with liver cirrhosis has not been extensively verified especially in the detection of early RI. Patients and Methods. Seventy consecutive potential candi...
Autores principales: | Omar, Mahmoud, Abdel-Razek, Wael, Abo-Raia, Gamal, Assem, Medhat, El-Azab, Gasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621358/ https://www.ncbi.nlm.nih.gov/pubmed/26550493 http://dx.doi.org/10.1155/2015/309042 |
Ejemplares similares
-
Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022) -
Cystatin-C as a Marker for Renal Impairment in Preeclampsia
por: Niraula, Apeksha, et al.
Publicado: (2017) -
Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment
por: Choe, Jung-Yoon, et al.
Publicado: (2010) -
Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
por: Woo, Kwang-Sook, et al.
Publicado: (2014) -
Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)